Brain-Boosting tablet workout tested for memory loss
NCT ID NCT07101380
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a tablet-based exercise program called SuperBrain BOOM can improve thinking, memory, and physical function in older adults with mild cognitive impairment (MCI). Forty-five participants aged 50-85 will use the program at home or in a clinic for 12 weeks, while a control group receives usual care. The goal is to see if the program is safe, engaging, and effective at slowing cognitive decline.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SuperBrain BOOM (tablet-based physical activity program)
What this could lead to
If it works, this could offer a simple, home-based exercise program to help slow cognitive decline and improve quality of life for people with mild cognitive impairment.
What could go wrong
This is a small, early-stage exploratory study with only 45 participants. The program may not show significant benefits, and results may not apply to everyone with MCI.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MILD COGNITIVE IMPAIRMENT (MCI) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ajou University Hospital
Suwon, Gyeonggi-do, 16499, South Korea
-
Bundang CHA General Hospital
Seongnam-si, Gyeonggi-do, South Korea
-
Chonnam National University Hospital
Gwangju, South Korea
-
Pusan National University Hospital
Busan, South Korea